Shuvra Ray

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Fecal loss of vedolizumab is associated with ulcerative colitis severity, lower serum vedolizumab levels, and rates of clinical response: results from the FAVOUR study.

Fecal loss of vedolizumab is associated with ulcerative colitis severity, lower serum vedolizumab levels, and rates of clinical response: results from the FAVOUR study.

Journal: Journal of Crohn's & colitis

Published: September 02, 2025

The angiotensin receptor blocker, losartan, reduces inflammation and fibrosis, and prevents relapse of fibrosis after steroid-induced remission, in mice prone to Crohn's disease-like ileitis.

The angiotensin receptor blocker, losartan, reduces inflammation and fibrosis, and prevents relapse of fibrosis after steroid-induced remission, in mice prone to Crohn's disease-like ileitis.

Journal: Journal of Crohn's & colitis

Published: May 20, 2025

A retrospective cohort study: pre-operative oral enteral nutritional optimisation for Crohn's disease in a UK tertiary IBD centre.

A retrospective cohort study: pre-operative oral enteral nutritional optimisation for Crohn's disease in a UK tertiary IBD centre.

Journal: Alimentary pharmacology & therapeutics

Published: December 20, 2021

Depression, anxiety, and stress among inflammatory bowel disease patients during COVID-19: A UK cohort study.

Depression, anxiety, and stress among inflammatory bowel disease patients during COVID-19: A UK cohort study.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: May 19, 2021

An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch.

An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch.

Journal: Alimentary pharmacology & therapeutics

Published: March 02, 2021

The effects of COVID-19 on IBD prescribing and service provision in a UK tertiary centre.

The effects of COVID-19 on IBD prescribing and service provision in a UK tertiary centre.

Journal: GastroHep

Published: August 11, 2020

Simultaneous Provocation Mesenteric Angiography With Coil Embolisation and Therapeutic Gastroscopy to Treat Occult Gastrointestinal Bleeding.

Simultaneous Provocation Mesenteric Angiography With Coil Embolisation and Therapeutic Gastroscopy to Treat Occult Gastrointestinal Bleeding.

Journal: The American journal of gastroenterology

Published: August 01, 2020

Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective.

Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective.

Journal: Inflammatory bowel diseases

Published: June 28, 2020

Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center Experience.

Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center Experience.

Journal: Inflammatory bowel diseases

Published: June 23, 2020

Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience.

Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience.

Journal: Journal of Crohn's & colitis

Published: April 14, 2020

Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO-LEVEL study.

Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO-LEVEL study.

Journal: Alimentary pharmacology & therapeutics

Published: March 20, 2020

Interleukin 33 Triggers Early Eosinophil-Dependent Events Leading to Metaplasia in a Chronic Model of Gastritis-Prone Mice.

Interleukin 33 Triggers Early Eosinophil-Dependent Events Leading to Metaplasia in a Chronic Model of Gastritis-Prone Mice.

Journal: Gastroenterology

Published: November 06, 2019

Showing 1-12 of 26

Last Updated: 09/26/2026